Quteba Ebrahem
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
Papers in
-
- Epigenetics and DNA Methylation 6
- Angiogenesis and VEGF in Cancer 3
- Hematology 15
- Acute Myeloid Leukemia Research 11
- Blood Coagulation and Thrombosis Mechanisms 4
- Co-authors
- Bela Anand‐Apte (15 shared papers)Jian Qi (5 shared papers)Gillian Murphy (2 shared papers)Andrew H. Baker (1 shared paper)Lena Claesson‐Welsh (1 shared paper)Nina Z. Moore (1 shared paper)Mark Bond (1 shared paper)Jonathan E. Sears (8 shared papers)
- Journals
- Blood (5 papers)Investigative Ophthalmology & Visual Science (3 papers)Advances in experimental medicine and biology (2 papers)The Anatomical Record (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Quteba Ebrahem
30 papers receiving 1.6k citations
Quteba Ebrahem's Hit Papers
Peers
Comparison fields: 5 of 97
- Ophthalmology 262
- Cancer Research 378
- Hematology 240
- Immunology and Allergy 74
- Molecular Biology 763
Countries citing papers authored by Quteba Ebrahem
This map shows the geographic impact of Quteba Ebrahem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quteba Ebrahem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quteba Ebrahem more than expected).
Fields of papers citing papers by Quteba Ebrahem
This network shows the impact of papers produced by Quteba Ebrahem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quteba Ebrahem. The network helps show where Quteba Ebrahem may publish in the future.
Co-authors
The 25 scholars most cited alongside Quteba Ebrahem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 Hit paper breakdown → | 2003 | 556 |
| 2 | 2013 | 111 | |
| 3 | 2009 | 99 | |
| 4 | 2008 | 98 | |
| 5 | 2006 | 98 | |
| 6 | 2005 | 63 | |
| 7 | 2009 | 60 | |
| 8 | 2006 | 59 | |
| 9 | 2011 | 54 | |
| 10 | 2012 | 51 | |
| 11 | 2002 | 48 | |
| 12 | 2010 | 43 | |
| 13 | 2011 | 36 | |
| 14 | 2012 | 32 | |
| 15 | 2013 | 32 | |
| 16 | 2014 | 28 | |
| 17 | 2010 | 25 | |
| 18 | 2014 | 19 | |
| 19 | 2013 | 14 | |
| 20 | 2007 | 11 |
About Quteba Ebrahem
Quteba Ebrahem is a scholar working on Molecular Biology, Hematology, Ophthalmology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Retinal Diseases and Treatments (8 papers), Epigenetics and DNA Methylation (6 papers), Protease and Inhibitor Mechanisms (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Retinal Imaging and Analysis (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Ophthalmology (262 citations), Cancer Research (378 citations), Hematology (240 citations), Immunology and Allergy (74 citations) and Molecular Biology (763 citations). Quteba Ebrahem has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Bela Anand‐Apte, Jian Qi, Gillian Murphy, Andrew H. Baker, Lena Claesson‐Welsh, Nina Z. Moore, Mark Bond, Jonathan E. Sears, Yogen Saunthararajah and Reda Z. Mahfouz. Their work appears in journals such as Blood, Investigative Ophthalmology & Visual Science, Advances in experimental medicine and biology, The Anatomical Record and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.